4D Pharma Announces Publication of Data Highlighting Immuno-Stimulatory Properties of MRx0518

LEEDS, England, January 29, 2019 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the publication of a paper outlining the mechanism and strong immuno-stimulatory effects of MRx0518. The paper 'The...

from PR Newswire: https://prn.to/2B7IJOE